You are here: Industry Insights > ICMR

News List

COVAXIN is well tolerated with no serious adverse events in Phase I trials expresspharma
December 18, 2020
The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants across 11 hospitals.
DCGI probe finds no adverse event linked to SII’s Covid-19 vaccine pharmaceutical-technology
December 04, 2020
The Drugs Controller General of India’s (DCGI) probe found that an alleged serious adverse event (SAE) suffered by a volunteer in Covid-19 vaccine trial of Serum Institute of India (SII) in Chennai was unrelated to the shot he received.
Homegrown COVID-19 vaccine final trials may conclude within two months: India expresspharma
November 24, 2020
ICMR and Bharat Biotech month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers.
Bharat Biotech commences Phase III trials for COVAXIN expresspharma
November 17, 2020
Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days apart.
IMCR and SII collaborate to develop Novavax’s Covid-19 vaccine in India pharmaceutical-technology
November 13, 2020
Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have collaborated for clinical development of the Covid-19 vaccine, COVOVAX, by US-based firm Novavax and upscaled by SII.
1600 participants enrolled for Phase III clinical trials of Covishield expresspharma
November 12, 2020
SII and ICMR are conducting Phase 2/3 clinical trial of COVISHIELD at 15 different centres, across the country.
Covaxin may get launched in February 2021: ICMR scientist expresspharma
November 06, 2020
The company had earlier hoped to launch it only in the second quarter of next year.
GoI publishes research procedure for COVID-19 vaccine candidates expresspharma
September 21, 2020
Over 30 vaccine candidates are in different stages of development in the country.
ICMR developing portal for info on COVID-19 vaccine expresspharma
August 24, 2020
ICMR is in the process of developing a vaccine portal which will provide information related to the COVID-19 vaccine development in India and abroad, with the majority of the updates in several regional languages in addition to English.
Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR expresspharma
August 20, 2020
A top ICMR official told a parliamentary panel that phase-two clinical trials of two indigenously developed COVID-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the Centre decides so.

Previous page 1 2 3 4 Next page